PKBO
Price:
$0.07
Market Cap:
$1.62M
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.[Read more]
Industry
Biotechnology
IPO Date
2021-03-15
Stock Exchange
NASDAQ
Ticker
PKBO
According to Peak Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.68M. This represents a change of 3.54% compared to the average of 13.21M of the last 4 quarters.
The mean historical Enterprise Value of Peak Bio, Inc. over the last ten years is 72.75M. The current 13.68M Enterprise Value has changed 1.78% with respect to the historical average. Over the past ten years (40 quarters), PKBO's Enterprise Value was at its highest in in the June 2022 quarter at 201.92M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.
Average
72.75M
Median
65.03M
Minimum
15.88M
Maximum
168.46M
Discovering the peaks and valleys of Peak Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.04%
Maximum Annual Enterprise Value = 168.46M
Minimum Annual Increase = -79.94%
Minimum Annual Enterprise Value = 15.88M
Year | Enterprise Value | Change |
---|---|---|
2023 | 15.88M | -79.94% |
2022 | 79.16M | -53.01% |
2021 | 168.46M | 159.04% |
2020 | 65.03M | 84.60% |
The current Enterprise Value of Peak Bio, Inc. (PKBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
87.83M
5-year avg
72.75M
10-year avg
72.75M
Peak Bio, Inc.’s Enterprise Value is less than Innovation1 Biotech Inc. (0), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (201.62K), greater than AVAX Technologies, Inc. (581.00), less than Molecular Partners AG (753.49M), greater than MediciNova, Inc. (-5896313.00), less than Anebulo Pharmaceuticals, Inc. (57.57M), less than Champions Oncology, Inc. (38.55M), less than Cyteir Therapeutics, Inc. (45.92M), less than null (61.85M), greater than null (-20511738.00),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $22.47K | |
0 | $581.00 | |
201.62K | $154.30M | |
581.00 | $6.89K | |
753.49M | $247.30M | |
-5896313.00 | $82.40M | |
57.57M | $49.01M | |
38.55M | $57.64M | |
45.92M | $108.71M | |
61.85M | $0 | |
-20511738.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Peak Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Peak Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Peak Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Peak Bio, Inc. (PKBO)?
What is the 3-year average Enterprise Value for Peak Bio, Inc. (PKBO)?
What is the 5-year average Enterprise Value for Peak Bio, Inc. (PKBO)?
How does the current Enterprise Value for Peak Bio, Inc. (PKBO) compare to its historical average?